Award
Delivery Order #SPE2DR26F40R8
Delivery Order for Dupixent Syringe Under AmerisourceBergen's Pharmaceutical Supply IDIQ
Buyer
Defense Logistics Agency
Award Amount
$13,105.36
Ceiling
$13,105.36
Awarded
February 22, 2026
Period of Performance
Feb 22, 2026 – Feb 23, 2026
Identifier
SPE2DR26F40R8
NAICS
424210
This award represents a delivery order contract issued under a significant indefinite delivery/indefinite quantity (IDIQ) contract previously awarded to AmerisourceBergen Drug Corporation, a leading pharmaceutical distributor. The current order procures the Dupixent 300 mg/2 ml syringe, an essential pharmaceutical product, ensuring timely access to this medication. Such deliveries are critical to maintaining continuous pharmaceutical supplies that support public health initiatives. The scope involves the procurement and delivery of the specified medication to a designated location in Conshohocken, Pennsylvania, within a concise one-day performance window. The contract is executed under competitive mechanisms associated with the parent IDIQ, reflecting a streamlined supply process. This short-term delivery order supplements the agency’s ongoing pharmaceutical supply needs, reinforcing AmerisourceBergen’s role as a reliable supplier within a long-term agreement spanning from 2025 to 2036.
Description
4570908768!DUPIXENT 300 MG/2 ML SYRINGE 2ML